Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology

Keyphrases

• Abraxane 50%
• Cancer Nanotherapeutics 50%
• Differentiated Products 50%
• Doxil 50%
• MM-398 50%
• Oncology Drug Development 50%
• Oncology Drugs 50%
• Preferential Retention 50%
• Tumor-associated Macrophages 50%
• Tumoral 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Cancer Drug Development 20%
• Enhanced Permeability and Retention Effect 20%
• Malignant Neoplasm 100%
• Nanomedicine 40%
• Nanoparticle 100%
• Neoplasm 40%
• Paclitaxel 20%
• Tolerability 20%